BOSTON — Patients with non-BRCA gene mutations undergoing risk-reduction surgery to prevent tubo-ovarian cancers showed no signs of tubo-ovarian high-grade serous carcinoma or serous tubal ...

For at-risk women who delay surgery, risk remains substantial at 50, especially with B ...

New Delhi, Oct 1 (PTI) A 40-year-old Delhi woman diagnosed with triple-negative breast cancer was found to carry a BRCA1 gene mutation, prompting doctors to treat her existing cancer while also taking ...

Chemoprevention has emerged as a promising strategy to reduce cancer incidence by using pharmacologic agents that interrupt the carcinogenesis process. This review discusses emerging insights and ...